Dashboard
1
Poor Management Efficiency with a low ROCE of 3.21%
- The company has been able to generate a Return on Capital Employed (avg) of 3.21% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 7.37% and Operating profit at -31.55% over the last 5 years
3
Positive results in Sep 25
4
With ROE of 3.26%, it has a expensive valuation with a 6.14 Price to Book Value
5
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,877 Million (Mid Cap)
188.00
NA
0.18%
-0.26
3.92%
1.88
Revenue and Profits:
Net Sales:
124 Million
(Quarterly Results - Sep 2025)
Net Profit:
13 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
70.72%
0%
70.72%
6 Months
77.86%
0%
77.86%
1 Year
122.07%
0%
122.07%
2 Years
270.84%
0%
270.84%
3 Years
123.99%
0%
123.99%
4 Years
87.95%
0%
87.95%
5 Years
0%
0%
0.0%
Inno Laser Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.37%
EBIT Growth (5y)
-31.55%
EBIT to Interest (avg)
-2.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.40
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
69.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.21%
ROE (avg)
3.60%
Valuation key factors
Factor
Value
P/E Ratio
188
Industry P/E
Price to Book Value
6.14
EV to EBIT
900.42
EV to EBITDA
120.59
EV to Capital Employed
8.12
EV to Sales
12.41
PEG Ratio
0.32
Dividend Yield
0.06%
ROCE (Latest)
0.90%
ROE (Latest)
3.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
124.00
97.40
27.31%
Operating Profit (PBDIT) excl Other Income
8.80
12.90
-31.78%
Interest
0.10
0.20
-50.00%
Exceptional Items
0.00
-0.20
100.00%
Consolidate Net Profit
13.30
6.30
111.11%
Operating Profit Margin (Excl OI)
71.30%
18.70%
5.26%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 27.31% vs 8.58% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 111.11% vs 520.00% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
444.90
366.10
21.52%
Operating Profit (PBDIT) excl Other Income
31.60
-3.70
954.05%
Interest
1.10
0.60
83.33%
Exceptional Items
0.10
0.20
-50.00%
Consolidate Net Profit
17.80
-5.30
435.85%
Operating Profit Margin (Excl OI)
-24.40%
-95.00%
7.06%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 21.52% vs 15.78% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 435.85% vs -122.18% in Dec 2023
About Inno Laser Technology Co., Ltd. 
Inno Laser Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






